Acadia Healthcare Co. (ACHC) PT Lowered to $66.00 at Robert W. Baird
Acadia Healthcare Co. (NASDAQ:ACHC) had its target price trimmed by Robert W. Baird from $67.00 to $66.00 in a research report sent to investors on Thursday. The brokerage currently has an outperform rating on the stock.
A number of other equities analysts have also recently issued reports on ACHC. Jefferies Group reissued a buy rating on shares of Acadia Healthcare in a report on Sunday, July 17th. Zacks Investment Research cut Acadia Healthcare from a hold rating to a sell rating in a report on Monday, July 11th. RBC Capital Markets reaffirmed an outperform rating and set a $78.00 price target (down previously from $86.00) on shares of Acadia Healthcare in a report on Monday, August 1st. Leerink Swann reaffirmed an outperform rating and set a $90.00 price target on shares of Acadia Healthcare in a report on Friday, July 15th. Finally, Royal Bank Of Canada cut their price target on Acadia Healthcare from $86.00 to $78.00 and set an outperform rating on the stock in a report on Monday, August 1st. One research analyst has rated the stock with a sell rating and twelve have issued a buy rating to the company. The company currently has an average rating of Buy and an average price target of $78.46.
Shares of Acadia Healthcare (NASDAQ:ACHC) opened at 51.03 on Thursday. The company has a 50-day moving average price of $51.73 and a 200-day moving average price of $55.57. The stock has a market cap of $4.46 billion, a price-to-earnings ratio of 27.26 and a beta of 0.84. Acadia Healthcare has a 1-year low of $48.05 and a 1-year high of $75.50.
Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Friday, July 29th. The company reported $0.73 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $0.73. Acadia Healthcare had a net margin of 6.44% and a return on equity of 9.35%. The firm had revenue of $756.50 million for the quarter, compared to analysts’ expectations of $752.57 million. During the same quarter last year, the company posted $0.57 earnings per share. Acadia Healthcare’s revenue was up 66.8% on a year-over-year basis. On average, equities analysts expect that Acadia Healthcare will post $2.64 earnings per share for the current fiscal year.
In other Acadia Healthcare news, COO Ronald Morgan Fincher sold 8,800 shares of Acadia Healthcare stock in a transaction that occurred on Monday, August 8th. The shares were sold at an average price of $52.56, for a total value of $462,528.00. Following the transaction, the chief operating officer now owns 120,780 shares in the company, valued at $6,348,196.80. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, major shareholder Waud Capital Partners Iii, L.L sold 457,443 shares of Acadia Healthcare stock in a transaction that occurred on Friday, September 16th. The stock was sold at an average price of $48.39, for a total transaction of $22,135,666.77. The disclosure for this sale can be found here. 17.20% of the stock is currently owned by company insiders.
A number of hedge funds and other institutional investors have recently bought and sold shares of ACHC. TimesSquare Capital Management LLC raised its position in Acadia Healthcare by 11.0% in the first quarter. TimesSquare Capital Management LLC now owns 1,234,005 shares of the company’s stock valued at $68,006,000 after buying an additional 121,940 shares during the period. JPMorgan Chase & Co. boosted its position in Acadia Healthcare by 17.7% in the first quarter. JPMorgan Chase & Co. now owns 4,748,547 shares of the company’s stock valued at $261,693,000 after buying an additional 715,472 shares during the last quarter. BlackRock Institutional Trust Company N.A. boosted its position in Acadia Healthcare by 23.7% in the first quarter. BlackRock Institutional Trust Company N.A. now owns 1,657,465 shares of the company’s stock valued at $91,343,000 after buying an additional 317,107 shares during the last quarter. BlackRock Fund Advisors boosted its position in Acadia Healthcare by 16.6% in the first quarter. BlackRock Fund Advisors now owns 776,809 shares of the company’s stock valued at $42,810,000 after buying an additional 110,692 shares during the last quarter. Finally, Prudential Financial Inc. boosted its position in Acadia Healthcare by 98.2% in the first quarter. Prudential Financial Inc. now owns 94,340 shares of the company’s stock valued at $5,199,000 after buying an additional 46,750 shares during the last quarter.
About Acadia Healthcare
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services. The Company operates in two segments: U.S. Facilities and U.K. Facilities. The Company develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities and facilities providing outpatient behavioral healthcare services to serve the behavioral health and recovery needs of communities throughout the United States, the United Kingdom and Puerto Rico.
Receive News & Ratings for Acadia Healthcare Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Co. and related companies with MarketBeat.com's FREE daily email newsletter.